News

Iconovo looks to the US where it now meets quality requirements

September 27, 2021

Biostock published September 24th an article about Iconovo that can be found in its entirety below One of Iconovo’s goals is to launch future inhalation…

Iconovo meets US Quality System regulation for medical devices

September 20, 2021

Iconovo AB (publ), that develops complete inhalation products for a global market today annonces that the company´s Quality Management System…

CEO Johan Wäborg, Pareto Securities´12th Annual Healthcare Conference September 2021

September 20, 2021

Pareto Securities´12th Annual Healthcare Conference CEO Johan Wäborg presents Iconovo.

Iconovo’s partner explores opportunities in Bangladesh

August 27, 2021

Biostock published August 27th an article about Iconovo that can be found in its entirety below Together with ISR, Iconovo is developing an inhaled…

Second ICOres® patent granted in Japan

August 26, 2021

Japan Patent Office has announced the intention to grant a patent (Notice of Allowance) regarding Iconovo’s inhalation device, ICOres. Iconovo…

Abbreviated interim report 1 January – 30 June 2021

August 24, 2021

Expanded agreement doubles royalty potential Key figures in TSEK unless otherwise indicated Apr-Jun 2021 Apr-Jun 2020 Jan-Jun 2021 Jan-Jun…

Iconovo receives order for nasal Covid-19 vaccine development

July 16, 2021

Biostock published July 16th an article about Iconovo that can be found in its entirety below Earlier this year, two Swedish life science companies,…

Iconovo receives an order for additional work from ISR for development of a nasal COVID-19 vaccine

July 12, 2021

Iconovo AB (publ), a company developing complete inhalation products for a global market, today announced that it has received an order from the…

Iconovo participates in vaccine race

July 8, 2021

Biostock published July 8th an article about Iconovo that can be found in its entirety below All Covid-19 vaccines on the market are given in injection…